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Abstract
Study Design & Setting—A cross-sectional, telephone survey of a representative sample of North
Carolina households in 2006.
Objective—The primary objectives of these analyses were to: describe health care use (providers,
medications, treatments, diagnostic tests) for chronic LBP and relate current patterns of use to current
best evidence for care of the condition.
Summary of Background Data—Chronic low back pain (LBP) is common and expensive. Prior
research on care utilization often was derived from medical claims databases, reflecting reimbursed
health care use, often by one payer.
Methods—5,357 households were contacted in 2006 to identify 732 noninstitutionalized adults 21
years and older with chronic LBP. 590 individuals sought care. Patient reported health care
utilization, comparison with efficacy as demonstrated by current systematic reviews.
Results—Individuals with chronic back pain were middle-aged (mean age 53 yrs), and the majority
were female (62%). Provider and treatment use was common and varied. 60% used narcotics in the
previous month. The mean number of provider visits was 21, and over-one third had an advanced
imaging procedure in the past year. Physical treatments were common, and often not supported by
evidence. Only 3% had engaged in a formal spine rehabilitation program. Half of patients not taking
antidepressants were positive on a two-item depression screen.
Limitations—Although this study was population-based, it was conducted in only one state.
Conclusions—Provider and treatment use for chronic LBP are both very common and varied.
Current treatment patterns are consistent with over-utilization of some medications and treatments,
and under-utilization of exercise and depression treatment.
Introduction
Chronic low back pain (LBP) is disabling, expensive and becoming increasingly common.1 
2 Recent work by our group in North Carolina has indicated that the prevalence of chronic
LBP has increased over the past 10–15 years, increasing in our recent study from 3.9% to
10.2% of the adult population3. We also found that the proportion of those who seek care has
also modestly increased.
Over the past 15 years the evidence base guiding the choice of effective treatments for
amelioration of symptoms and improvement in functioning has grown substantially. The
clinical trials literature in back pain has markedly increased; providers and patients now have
access to a substantial database from which to guide choices among tests and treatments.
Ideally, providers make test and treatment choices based on their experience, the best available
evidence, and the clinical characteristics of the patient. Provider choices of care may also be
influenced by other factors such as scope of practice. For example, care provided by a physical
therapist will differ, in some ways, from care provided by a physician. Even within the same
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profession, providers’ choices of care may vary depending upon the degree to which they are
aware of current evidence on treatment effectiveness and the degree to which they choose to
incorporate the evidence into their practice. Treatment choices may also be influenced by
patients, first by the types of providers they choose to see, which will influence the types of
treatments received; and second by their interactions with providers.
The focus of our study is to begin to understand whether we are choosing tests and treatments
for chronic LBP wisely. We examine population-based survey data from patients with chronic
LBP and recent systematic reviews on the efficacy and effectiveness of tests and treatments
for patients with chronic LBP to achieve the following objectives: 1) describe health care use
(providers, medications, treatments, diagnostic tests) for chronic LBP and 2) to relate current
patterns of use to current best evidence for care of the condition. We were specifically interested
in identifying areas where ineffective or minimally effective treatments may appear to be over-
utilized, and conversely, areas where effective options may be under-used, since these represent
opportunities for care improvement. Examining the concordance or lack of concordance
between available best evidence and current treatment patterns can hopefully influence
guideline dissemination as well as other interventions, such as payment reform, to improve the
effectiveness of current care for back pain. Greater use of treatments that relied more on
marginally effective technology and were of greater cost would be examples of evidence non-
concordant care.
Methods
We conducted a population-based survey of patients with chronic, impairing low back and
neck pain in North Carolina. Since this survey was not based on insurance claims, we were
able to query patients regarding all types of care, regardless of their insurance status or payment
source. The study was conducted in North Carolina as a continuation of work in the state for
over 15 years. North Carolina is characterized by a racially diverse population with a mixture
of urban and rural populations. Survey data has the advantage over analysis of claims data or
chart-based information since we can sample individuals with back pain regardless of their
type of insurance or where or whether they sought care, yielding highly generalizable
information. Although some information on back pain care can be gleaned from national
surveys such as the Medical Expenditure Panel Survey (MEPS), the functional status of those
individuals is unclear since the back pain questions are a small part of a general health status
questionnaire. 4
Sampling
The sampling for the 2006 back and neck pain survey in North Carolina has been described in
detail elsewhere3. We used standard telephone survey methods, randomly selecting residential
households. At each contacted household, an adult completed the household roster. If one or
more adults in the household had a history of back or neck problems in the past few years, one
individual was randomly selected to be interviewed in more detail to determine whether s/he
had chronic pain. We defined chronic pain as symptoms lasting greater than 3 months or over
24 separate episodes of back or neck pain in the previous year. Back and neck pain had to be
sufficiently impairing so as to interfere with the respondents usual daily activities. Individuals
who reported both chronic back and neck pain completed the questions on back pain.
A stratified probability sample of North Carolina telephone numbers was obtained from
GENESYS Sampling Systems,5 the sampling vendor for this study. Numbers were chosen
from six sampling strata, defined by the cross-classification of two stratification variables: 1)
region of the state (mountains, piedmont, coastal) and 2) concentration of African-Americans
in the population. The latter variable was chosen to ensure adequate representation of African-
Americans.
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5,357 households with one or more adults 21 years or older were contacted and 9,924 adults
were rostered. The household response rate was 66 percent and was computed as the sum of
households interviewed divided by the sum of eligible households plus an estimate of the
proportion of households with unknown eligibility.6 The latter variable accounts for
households with unknown eligibility that, if called an indeterminant number of times, would
more than likely have been eligible.
Of the 5,357 households contacted, 3,276 households had one or more adults with a history of
back and/or neck pain. Of the adults randomly selected from each household (n=3,276), 2,809
were interviewed for an individual response rate of 86 percent and an overall response rate of
57 percent. The overall response rate is the product of the household response rate (66%) and
the individual response rate (86%). Non-responders were similar in age and race, relative to
responders, but non-responders were more likely to be male (chi square test, p<.001).
Interview—Over the course of the 35 minute survey, respondents with chronic back or neck
pain were queried regarding health care provider visits, treatments, and tests during the
previous year (survey instrument available from researchers on request). Respondents were
specifically queried about whether they saw each of the following provider types: primary care
physician, orthopedic surgeon, neurologic surgeon, doctor of chiropractic, physical medicine
and rehabilitation physician, anesthesiologist, neurologist, rheumatologist, psychiatrist,
physical therapist, acupuncturist, and other. Respondents also told us how many visits they
conducted with each type of provider. Respondents who indicated seeing one or more provider
were specifically queried regarding named diagnostic tests (CT, MRI, nerve conduction, etc.)
and physical treatments (ultrasound, spinal manipulation, massage, physical therapy, etc.)
used. The window of recall for providers, treatments, and tests was the previous year.
All respondents were also queried regarding medications they took in the previous month, since
the accuracy of recall of medication use drops sharply as the ‘window’ of recall extends.7
Respondents were specifically asked about over the counter and prescription drug use including
narcotics, muscle relaxants, and depression medication. Common names for drugs in each
category were specifically listed by the interviewer. Respondents who indicated taking
narcotics were asked about frequency of use (every day, as needed, occasionally). The window
of recall for medications was restricted to the previous month due to limited recall regarding
medications taken in the remote past. Pilot work by our group indicated that recall on number
of provider visits in the past year, when compared with chart abstraction, was good, with a
correlation between the two measures of visit number of 0.83.
Data Analysis—All analyses were conducted using SAS or Stata (ver 9.2). We primarily
conducted descriptive analyses to describe health care utilization. Comparisons between
groups used standard parametric and non-parametric statistical tests. All results are weighted
to reflect the complex sampling design, 95% confidence intervals were generated for all point
estimates. The results therefore reflect the population of the state.
We utilized the systematic review conducted by the American College of Physicians (ACP)
and the American Pain Society, in addition to active Cochrane Collaboration systematic
reviews to represent the current “best evidence” available to patients and providers. The ACP
review is methodologically rigorous and recent.8 9 Cochrane reviews are characterized by
extensive peer review and methods consistency; recent reviews were available for many of the
treatments surveyed. Although multiple other systematic reviews for ‘back pain’ are available,
we chose these two sources for the above reasons. In our tables we summarized the review
conclusions as positive (+), negative (−) or “unable to estimate” for each modality or
medication. The ACP review also used terms such as “small” or “moderate” to describe the
magnitude of the effect of the treatment, if effective. We did not use formal statistical tests
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when comparing current health care utilization patterns with ‘best evidence’ as described in
formal reviews.
Results
Of the 2,809 individuals interviewed, 732 indicated that they had chronic LBP and 141
indicated they had chronic neck pain. This analysis focuses on the 706 individuals with chronic
LBP who completed the sections on provider, treatment, and test use. We chose to focus our
analysis on back rather than neck pain due to the much more complete data base regarding
treatment effectiveness for back compared with neck pain. Of the 706 patients with chronic
LBP, 84% (590) had at least one visit to a provider. Those who did not seek care had somewhat
better functional status and were of lower socioeconomic status than those who did seek care.
The demographics of the individuals who sought care are presented in Table 1. These
individuals are middle-aged, slightly more likely to be female than male, and very disabled.
They have high pain scores with a mean of 7 on a 0–10 pain scale, and have poor functional
status, similar to that of patients seeking consultation for consideration of spine surgery in other
studies.10 Their mean Roland back-specific disability score is 15 (0–23 scale) with a SF-12
physical component subscale of 31.
Medication Use
Medication use by those who did and did not see a provider in the previous year is presented
in Table 2. These patients, therefore, utilized self care as their primary treatment. They reported
no provider contact, making it unlikely that physicians would phone in prescription refills for
patients who they had not seen. Medication use was common among the 116 patients who did
not see a provider. Utilization of over-the-counter (OTC) medications such as non-steroidal
anti-inflammatory agents (53%) and use of acetaminophen (65%) was common. These rates
of use of OTC medications were similar to the OTC use of patients who saw health care
providers in the previous year. Surprisingly, 15% of non-care seeking individuals took weak
narcotics such as codeine or tramadol and 6% took strong narcotics such as oxycodone in the
month prior to the interview. Six percent of patients took tricyclic anti-depressants or anti-
convulsants, and 9% took anti-depressants. We did not ask these patients how they obtained
these medications. While its possible they have been called in through phone prescriptions by
a provider whom they had not seen in the past year, the medications may also have been
obtained through relatives or other “gray market” means.
Poly-pharmacy was extremely common for those who saw a provider. Forty-seven percent of
patients took strong narcotics such as oxycodone, morphine or fentanyl, and 33% a weak
narcotic. A total of sixty-one percent of patients were taking some sort of narcotic medication
in the previous month. Thirty-one percent of patients took a muscle relaxant. Patients taking
narcotic medications were more likely to have taken muscle relaxants in the past 30 days
relative to patients who did not take narcotics (41.3% vs 9.2% p<.001).
Table 2 also indicates whether each medication has been assessed as efficacious by recent
systematic reviews. Recent guidelines by the American College of Physicians (ACP) have
discouraged the long-term use of muscle relaxant medications Twenty-six percent of patients
were taking both a narcotic and muscle relaxant in spite of little evidence of the efficacy of the
muscle relaxants in chronic back pain7. Only 18% of patients were taking a tricyclic anti-
depressant or anti-epileptic agent to serve as a pain-modulating agent. Tricyclic anti-
depressants have a fairly good evidence base of partially ameliorating chronic back pain; the
evidence base for anti-epileptic medications such as gabapentin is somewhat weaker.
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Patients taking narcotic medications in the past 30 days were more disabled than patients not
taking narcotics, with higher Roland scores (mean 17.4 vs 11.9, p<.001) and lower SF-12
physical function scores (mean 28.2 vs.35.0, p<.001). Their pain ratings over the past 3 months
were also higher (mean 7.2 vs 6.3, p<.001), they were more likely to have a positive depression
screen (64.0% vs 44.6%, p<.001), and they had lower SF-12 mental health scores (mean 45.1
vs 50.3).
Provider Use and Visits
Table 3 presents descriptive data on provider use and visits. Seventy-six percent of subjects
saw a primary care provider and almost half saw an orthopedic or neurologic surgeon. Physical
therapists and chiropractors were the next most frequent types of providers seen. Overall
provider use and visits were extremely common, averaging 2.7 provider types per year (range
of 1 – 11) and 21.2 visits (across all providers) per patient per year. The number of visits ranged
from one visit (9% of patients) to over 40 total visits per year (13% of patients). Chiropractors
and physical therapists saw patients most frequently with a mean number of visits of 21 and
16 respectively. Mean number of visits to physician types ranged from 3–6 visits.
Use of Diagnostic Tests
Although these patients had chronic back pain for a long period of time (average of 10 years
of continuous pain), utilization of diagnostic tests remained common (Table 4). Forty-six
percent received plain radiographs in the previous year and 36% received CT or MRI scans.
Of those patients who received a CT or MRI scan, 52% received a second advanced imaging
test within the year of reporting. Although the evidence base is limited, multiple imaging tests
in the absence of indications for surgery are discouraged by ACP guidelines6. In our sample,
for each patient who received surgery in the previous year, 5 patients had advanced imaging
studies.
Use of Physical Treatments
We found that utilization of physical treatments was both common and varied. Table 5
illustrates the proportion of respondents using the treatment and whether the treatment was
assessed effective by the recent ACP review or Cochrane reviews. Use of treatments
demonstrated to be moderately effective in recent systematic reviews (NSAIDs or structured
exercise) were more than balanced by common use of treatments characterized by evidence of
only marginal efficacy or even, in some cases, with either no evidence of efficacy or significant
evidence of lack of efficacy. For example, one third of individuals received one of the following
treatments which have minimal to no evidence of efficacy: traction (6%) corset or brace (19%),
or a TENS unit (19%). In addition, marginally effective treatments such as electro-stimulation
(21%, average of 20 treatments per patient) and ultrasound (16%, average of 8 treatments per
course) are concerning examples of potential over-use. At the same time, less than half of the
patients were prescribed exercise, only 30% of patients saw a physical therapist in the previous
year (Table 3), and only a small number (3%) were in a structured rehabilitation program, one
of the few treatments for which there is moderate evidence of efficacy.
Depressive symptoms were very common among patients with chronic back pain who sought
care (Table 6). We utilized a two-item depression screen. If a patient answered “yes” to either
of the questions: “Over the past year, have you had 2 weeks or more during which you felt sad,
blue or depressed, or when you lost all interest or pleasure in things you usually cared about
or enjoyed?” or “Have you felt depressed or sad much of the time in the past year?”, s/he was
considered to have a positive depression screen. Previous research has demonstrated that these
patients have a high likelihood of having serious depression.11
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Fifty-four percent of patients with chronic back pain had a positive depression screen. Of those
with a positive depression screen only 38% were taking anti-depressant medications. Even
among those taking antidepressants, substantial numbers of patients were simultaneously
taking muscle relaxant medications, which can be sedating. In contrast, among patients with a
negative depression screen 16% took anti-depressant medication. Only 12% of those with a
positive depression screen saw a psychiatrist or psychologist in the previous year.
Discussion
A large majority of individuals with chronic low back pain seek care from more than one
provider and receive a number of tests and treatments. These tests and treatments often do not
reflect the best evidence for effective treatment of this chronic and disabling condition. Some
treatments, such as use of therapeutic exercise, appear to under-utilized, while other treatments,
such as utilization of muscle relaxants, advanced imaging studies, and physical modalities such
as traction, TENS units, and corsets, appear to be substantially over-utilized. Consistent with
other literature we found very high utilization of narcotics.4 Utilization of narcotics has
increased substantially in recent years, possibly in response to efforts to make pain the “fifth
vital sign” and concern regarding under-treatment of pain.12 However, consistent with
systematic reviews, we found that patients on narcotics had poor physical functioning and there
was significant evidence of depression with poor SF-12 mental functioning scores.13 Patients
on narcotics were also more likely to have a positive depression screen, relative to those not
on narcotics. While some of the findings from our respondents could be due to confounding
by indication (worse functioning patients are more likely to be placed on narcotics by their
providers), our findings reinforce the need for appropriately sized placebo-controlled trials of
narcotics for chronic pain. Certainly these chronically ill patients do not seem to be substantially
benefiting from their medications, and they are at risk for significant side effects.
The burden of un- or under-treated depression in this population is substantial. Depression rates
are known to be increased in chronic pain patients and treatment with medication or cognitive-
behavioral therapy can lead to substantial improvement in depressive symptoms, although not
necessarily in level of physical functioning.14 15 We recommend greater efforts towards case-
finding and treatment of depression in the chronic back pain population.
The strengths of this study are the ability to generalize the sample to a defined population with
demographics similar to the rest of the US, and the lack of restrictions by payment source or
type of care sought. The second strength is the specific definition of back pain: respondents
had to identify the problem as sufficiently severe that they could not perform their usual
activities of daily living and lasting greater than 3 months in duration- providing information
on the clinical syndrome associated with the majority of spine disability and social cost.16 Our
measures of functional status, care utilization and depressive symptoms were based on standard
measures. Our study does have several limitations. We could not link care received with the
identity of the provider who recommended that care; we found in pretesting that patients could
not reliably identify which of their often multiple care providers prescribed specific tests,
medications or treatments. As a cross sectional survey we cannot track the individuals over
time to determine the course of their impairment, although other literature has demonstrated
that chronic back pain, once established, is persistent.17 The measures of effect in the
systematic reviews we examined were almost always assessed as an average effect; evidence
is generally lacking in the constituent studies in subset analyses by age, gender, comorbidity,
or other clinical criteria. Even when there is no overall benefit from a treatment, some individual
patients may benefit, but current evidence generally cannot guide us toward what those patient
subsets are.
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The reasons for the marked disparities between care provided and best evidence care are likely
multiple. Under use of treatments such as exercise instruction may serve as a marker for care
that is poorly reimbursed and/or provided by individuals other than physicians. Exercise may
also have relatively low acceptance among patients with high expectations that use of advanced
technology will be an answer to their chronic back pain. However, in recent years exercise
programs such as cardiac rehabilitation have gained somewhat greater acceptance through
more structured programs and improved insurance reimbursement, with now 30% of eligible
patients participating.18 Less than half of back pain patients received any exercise prescription
and only a small number were in a formal program. Detailed examination of the reasons for
lack of dissemination of such structured programs for chronic back pain is needed. Reasons
could include poor reimbursement, lack of trained providers, provider and patient knowledge,
and acceptability.
Other over-utilized tests and treatments may be subject to the allure of technology (MRIs, CT
scanning), and treatments that address short term symptom relief without a sufficient focus on
long-term functioning (narcotics, muscle relaxants and electro-stimulation, among others).
Treatment for depression may be under-utilized due to lack of recognition by health care
providers. Published guidelines are now available but past experience has demonstrated that
simply publishing guidelines will not substantially change care patterns, and adherence to
guidelines is often poor.19 20 Untreated depression makes other components of treatment of
chronic back pain more difficult; depression and back pain are risk factors for each other.21
High rates of utilization of CT and MR, narcotics, muscle relaxants and under-use of more
effective test and treatments remain. Concerted efforts by professional groups, insurers and
health policy makers are needed to substantially change treatment patterns, which currently
result in poor distribution of health care resources for this common and disabling illness.
Reallocation of resources and reimbursement away from ineffective or potentially harmful
treatments to more effective treatments has the potential to substantially ameliorate this public
health crisis.
Key Points
1. Care utilization for chronic low back remains very high, including high rates of use
of advanced imaging, narcotics, and physical treatments.
2. Use of evidence-based treatments such as treatment of depression and use of exercise
was low when compared with current best evidence.
3. Multiple treatments appeared to be over-utilized, including use of muscle relaxants,
traction, and braces.
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Table 1
Demographic and Clinical Characteristics of Individuals who Sought Care for
Chronic, Disabling Low Back Pain (N=590)
Estimate (95% CI)
Demographic Characteristics
 Age, mean 53.0 (51.8 – 54.3)
 Female, % 62.3 (58.3 – 66.5)
 Race, %
  White 71.6 (68.2 – 75.0)
  Black 18.3 (15.7 – 20.8)
  Latino 4.9 (3.0 – 6.7)
 Employed past 3 mos, % 35.9 (31.7 – 40.1)
Clinical Characteristics
 Years with chronic back pain, mean 9.8 (8.8 – 10.7)
 Roland disability score,a mean 14.9 (14.3 – 15.5)
 Pain severity b past 3 mos, mean 6.8 (6.6 – 7.0)
 SF-12 PCS, mean 31.4 (30.5 – 32.3)
 SF 12 MCS, mean 47.7 (46.7 – 48.7)
 Previous spine surgery, % 25.1 (21.5 – 28.7)
a
On a 0–23 scale
b
On a 0–10 scale
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Table 2
Medication Use in Previous 30 Days
No Provider Visits in
Past Year (n=116)
Provider Visits in Past
Year (n=590)
Variable Estimate (95%CI) Estimate (95%CI) ACP Cochrane
OTCa Medication, %
 Acetaminophen 64.7 (54.8 – 74.5) 68.3 (64.0 –72.5) Small
 NSAIDs 53.4 (43.2– 63.7) 53.9 (49.3 – 58.5) Moderate +19
 Aspirin 49.3 (38.6– 59.9) 42.0 (37.4 – 46.4)
Prescription Medication, %
 Weak narcotics 14.7 (7.3– 22.3) 32.8 (28.4–37.1) Moderate
 Strong narcotics 5.9 (2.0–9.80) 47 (42.5–51.7) Moderate +-1
 Prescription NSAIDs 15.3 (8.4–22.3) 42.1 (37.6– 46.6) Moderate +2
 Muscle relaxants 5.5 (1.2–9.8) 30.6 (26.3 – 34.8) Unable to est. +3
 TCA/anticonvulsants 5.6(1.3–9.9) 17.8 (14.2– 21.4) Small-Mod
 Antidepressants 8.7 (3.3–14.1) 27.5 (23.5–31.6) Small-Mod +-14
 Steroids 3.4 (0 – 7.6) 14.5 (11.3–17.7) Unable to est.
Combinations, %
 Strong or weak narcs. 60.5 (56.0– 65.0)
 Strong & weak narcs 19.5 (15.9– 23.1)
 NSAIDS & narcs 41.6 (37.2–46.1)
 Muscle relaxants & narcs 25.7 (21.7–29.7)
 TCA/AED & narcs 14.2 (10.9–17.6)
Clinical Characteristics, mean
 Pain severityb past 3 mos 6.7 (6.2 – 7.2) 6.8 (6.6 – 7.0)
 Pain severityb today 5.0 (4.4 – 5.5) 5.6 (5.3 – 5.8)
 Roland disability score c 12.3 (10.8 – 13.8) 15.4 (14.8 – 16.0)
 SF-12 PCS 36.2 (33.7 – 38.6) 30.4 (29.5 – 31.4)
 SF-12 MCS 49.3 (47.1 – 51.5) 47.4 (46.2 – 48.5)
a
Over-the-counter medication
b
On a 0–10 scale
c
On a 0–23 scale
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Table 3
Health Care Provider Use in Past Year Among Careseekers (n=590)
Percent Use (95% CI) Mean number of visitsa, (95% CI)
Primary care provider 76.0 (72.0 – 80.0) 5.4 (4.7 – 6.1)
Orthopedic/neurologic surgeon 42.0 (37.4 – 46.5) 5.1 (4.3 – 5.9)
Neurologist 14.0 (10.9 – 17.1) 3.1 (2.2 – 3.9)
Physical medicine and rehabilitation
(PM&R)
18.2 (14.6 – 21.7) 5.9 (4.6 – 7.2)
Doctor of chiropractic 26.9 (22.8 – 31.0) 20.8 (16.4 – 25.2)
Anesthesiologist 15.8 (12.5 – 19.1) 4.2 (3.3 – 5.2)
Rheumatologist 14.1 (10.8 – 17.4) 4.0 (2.9 – 5.1)
Psychiatrist/psychologist 7.1 (5.7 – 9.5) 10.5 (4.3 – 16.8)
Physical therapist 29.7 (25.7 – 33.8) 15.6 (11.9 – 19.3)
a
among those who saw the provider
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Table 4
Utilization of Diagnostic Tests in the Previous Year Among Careseekers (n=590)
Test Percent Receiving (95% CI) Number of testsa, mean (95% CI)
CT 17.8 (14.3 – 21.3) 1.5 (1.3 – 1.7)
MRI 33.2 (28.8 – 37.6) 1.3 (1.2 – 1.4)
CT and/or MRI 36.2 (31.7 – 40.7) 1.9 (1.7 – 2.1)
Spine radiographs 45.8 (41.2 – 50.4) 2.2 (1.9 – 2.5)
Spine radiographs and CT and/or MRI 30.4 (26.1 – 34.7) 4.6 (4.0 – 5.2)
Myeologram/discogram 4.8 (2.9 – 6.7) 1.2 (1.0 – 1.3)
Nerve conduction 7.2 (4.9 – 9.5) 1.1 (1.0 – 1.3)
a
among those who received a test
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Table 6
Characteristics of Patients Who Did and Did not Use Antidepressant Medications in Past 30 days
Characteristic Antidepressant use (n=166) Estimate
(95% CI)
No antidepressants (n=420) Estimate
(95% CI)
Depression screen positive, % 73.6 (65.7 – 81.4) 46.9 (41.2 – 52.5)
Saw mental health professional, % 15.4 (9.2 – 21.7) 4.0 (1.8 – 6.2)
SF-12 MCS, mean 42.0 (39.9 – 44.2) 49.4 (48.2 – 50.7)
SF-12 PCS, mean 29.0 (27.7 – 30.4) 31.0 (29.8 – 32.1)
Roland disability scale a, mean 16.6 (15.5 – 17.6) 14.9 (14.2 – 15.7)
Pain severity b past 3 months, mean 7.1 (6.7 – 7.4) 6.7 (6.5 – 6.9)
Pain severity today c, mean 6.1 (5.6 – 6.5) 5.4 (5.1 – 5.7)
Strong or weak narcotics, % 70.4 (62.3 – 78.5) 56.8 (51.4 – 62.2)
Muscle relaxants, % 37.1 (29.0 – 45.2) 28.2 (23.2 – 33.2)
Narcotics and muscle relaxants, % 30.7 (23.2 – 38.1) 24.0 (19.2 – 28.7)
a
On a 0–23 scale
b
On a 0–10 scale
c
On a 0–10 scale
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